Article

The Ketogenic Diet for the Treatment of Pediatric Status Epilepticus

Department of Pediatrics, Section of Epilepsy, Lurie Children's Hospital, Chicago, Illinois. Electronic address: .
Pediatric Neurology (Impact Factor: 1.5). 11/2013; 50(1). DOI: 10.1016/j.pediatrneurol.2013.07.020
Source: PubMed

ABSTRACT Refractory status epilepticus carries a high risk of morbidity and mortality for children. Traditional treatment of status epilepticus consists of multiple anticonvulsant drugs and, if needed, induction of a medical coma. The ketogenic diet has been used for intractable epilepsy for many years. The purpose of this article is to report a case series of five patients with refractory status epilepticus successfully managed with the ketogenic diet.
A summary of pediatric patients with refractory status epilepticus treated with diet was performed.
Ketogenic diet therapy should be considered as a treatment option in pediatric patients with refractory status epilepticus.

Download full-text

Full-text

Available from: Beth Zupec-Kania, Apr 02, 2014
2 Followers
 · 
200 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The post-injury period of glucose metabolic depression is accompanied by adenosine triphosphate decreases, increased flux of glucose through the pentose phosphate pathway, free radical production, activation of poly adenosine diphosphate ribose polymerase via DNA damage and inhibition of glyceraldehyde dehydrogenase (a key glycolytic enzyme) via depletion of the cytosolic nicotinamide adenine dinucleotide pool. Under these post-brain injury conditions of impaired glycolytic metabolism, glucose becomes a less favorable energy substrate. Ketone bodies are the only known alternative to glucose for cerebral energy metabolism. Preclinical studies employing both pre-and post-injury implementation of the ketogenic diet have demonstrated improved structural and functional outcome in traumatic brain injury models, mild TBI/ concussion models, and spinal cord injury. Further clinical studies are required to determine the optimal method to induce cerebral ketone metabolism in the post-injury brain, and to validate the neuroprotective benefits of ketogenic therapy in humans.
    The Journal of Lipid Research 04/2014; DOI:10.1194/jlr.R046706 · 4.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Automated lipidomic methods based on mass spectrometry (MS) are now proposed to screen a large variety of candidate drugs available that inhibit de novo lipid synthesis and replace tedious methods based on radiotracer incorporation. A major new interest in inhibitors of de novo lipogenesis is their proapoptotic effect observed in cancerous cells. Areas covered: In this review, the authors focus on the screening methods of antilipogenic inhibitors targeting the synthesis of malonylCoA (carbonic anhydrase, acetylCoA carboxylase), palmitylCoA (fatty acid synthase condensing and thioesterase subunits) and monounsaturated fatty acids (Δ9-desaturase). The consequences of inhibition depend on how the pathway deviates above the blockade: accelerated mitochondrial fatty acid oxidation following the decreased malonylCoA level, accumulation of ketone bodies and increased cholesterol synthesis following the increased acetylCoA level. Side effects such as anorexia and skin defects may critically decrease therapeutic indices in the long term. The authors emphasize the need for assessment of toxicity in short-term treatments inducing proapoptotic effects observed in aggressive hormone-dependent malignancies. Expert opinion: The activity of lipogenesis inhibitors can be recognised in lipid profiles established by a combination of MS-based measurements and multivariate analysis processing hundreds of lipid molecular species. Because the method can be automated, it is suitable for screening large chemical libraries, with particular focus on anticancer activities.
    Expert Opinion on Drug Discovery 05/2014; DOI:10.1517/17460441.2014.914026 · 3.47 Impact Factor
  • Pediatric Neurology 08/2014; DOI:10.1016/j.pediatrneurol.2014.03.016 · 1.50 Impact Factor

Questions & Answers about this publication

  • David Camacho-Valadez added an answer in Internet Search:
    What is the Root Cause of Epilepsy?

    From Internet search Epilepsy is “a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain”.

    What is the root cause that trigger Epilepsy?

    Are the root cause the same for children and adult?

    Which is the best treatment for Epilepsy?

    Can we prevent Epilepsy from relapse for a person who is suffering from Epilepsy? or medical treatment is the only way?

    Can Epilepsy disappears or goes away by itself after a while or will it lasts for the whole life?  If yes how long?

    Is there any negative impact on a child e.g. confidence level, introvertedness,  slow in learning, reduction in IQ & EQ etc when s/he realized s/he has contracted with Epilepsy i.e. happen for many times / episodes of fits?

    Feel free to share your professional comments / advice.  Thanks.

    David Camacho-Valadez · Universidad Autónoma de Ciudad Juárez

    Hello, take a look at this current articles (perhaps you've already read).

    The first one for adults, the another two are in children population. 

    I hope can be useful to you.

    Kaski, D., & Cockerell, C. (2015). Advances in the diagnosis and management of epilepsy in adults. Prescriber, 26(3), 12-19.

    O'Connor, S. E., Richardson, C., Trescher, W. H., Byler, D. L., Sather, J. D., Michael, E. H., ... & Zupec-Kania, B. (2014). The ketogenic diet for the treatment of pediatric status epilepticus. Pediatric neurology, 50(1), 101-103.

    Meeraus, W. H., Petersen, I., & Gilbert, R. (2015). Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network. PloS one, 10(3), e0122034.